NICE recommends ALK’s tree pollen tablet, Itulazax for use in the UK health system: Hørsholm, Denmark Tuesday, July 22, 2025, 16:00 Hrs [IST] ALK, a global specialty pharmaceut ...

A once-daily tablet that can help people suffering from hay fever caused by birch tree pollen, Alk-Abelló's Itulazax, has ...

Denmark-based allergy immunotherapy specialist ALK Abello today announced that the UK’s National Institute for Health and ...

ALK (ALKB:DC / OMX: ALK B) today announced that the National Institute for Health and Care Excellence (NICE) has recommended the use of the company’s tree pollen tablet ITULAZAX® for the treatment in ...

The Saudi Arabia Allergy Vaccine Market is witnessing significant growth driven by several factors such as increasing prevalence of allergies, rising awareness about treatment options, and ...

Many mistake allergic rhinitis for a cold, but testing like skin prick tests and targeted treatments such as immunotherapy ...

BNT23001 is designed to offer a patient-friendly alternative to traditional oral cladribine tablets, such as Mavenclad®, by providing a rapidly dissolving sublingual film. This delivery method aims to ...

A high-fiber diet may improve response rates and event-free survival outcomes in patients with advanced melanoma receiving standard immunotherapy.

BCG therapy—the gold standard treatment for non-muscle invasive bladder cancer (NMIBC), where the cancer has not penetrated the muscle layer—is one of the earliest forms of cancer ...

80% of colorectal cancers resist immunotherapy—this DNA treatment could help by Gillian Rutherford, University of Alberta edited by Lisa Lock, reviewed by Robert Egan Editors' notes ...